248 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).
University of California
High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators.
University of California
Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases.
University of California
Dimethylsulfonium and thiolanium analogues of the muscarinic agent oxotremorine.
University of California
Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa.
University of California
Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIß.
University of California
A potent and selective inhibitor targeting human and murine 12/15-LOX.
University of California
Discovery, synthesis and structure-activity analysis of symmetrical 2,7-disubstituted fluorenones as urea transporter inhibitors.
University of California
Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease.
University of California
Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1.
University of California
Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release.
University of California
New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristics.
University of California
Structure-based design of bacterial nitric oxide synthase inhibitors.
University of California
Exploring the influence of the protein environment on metal-binding pharmacophores.
University of California
Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.
University of California
Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.
University of California
Structure-Activity Relationship of Semicarbazone EGA Furnishes Photoaffinity Inhibitors of Anthrax Toxin Cellular Entry.
University of California
Novel inhibitors of alpha 4 beta 1 integrin receptor interactions through library synthesis and screening.
University of California
Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins.
University of California
Optimization of Arylamides as Novel, Potent and Brain-penetrant Antiprion Lead Compounds.
University of California
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
University of California
Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
University of California
ABSOLUTE CONFIGURATION AND BIOLOGICAL PROPERTIES OF ENANTIOMERS OF CFTR INHIBITOR BPO-27.
University of California
Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir.
University of California
Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.
University of California
Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrinavß3.
University of California
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
University of California
Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.
University of California
Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).
University of California
Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
University of California
Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
University of California
Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors.
University of California
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro.
University of California
A new strategy for detection and development of tractable telomerase inhibitors.
University of California
Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
University of California
Symplocin A, a linear peptide from the Bahamian cyanobacterium Symploca sp. Configurational analysis of N,N-dimethylamino acids by chiral-phase HPLC of naphthacyl esters.
University of California
An Optimized Immunoaffinity Fluorescent Method for Natural Product Target Elucidation.
University of California
Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).
University of California
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.
University of California
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
University of California
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
University of California
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway.
University of California
Bastadin 20 and bastadin O-sulfate esters from Ianthella basta: novel modulators of the Ry1R FKBP12 receptor complex.
University of California
Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
University of California
Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
University of California
A surface on the androgen receptor that allosterically regulates coactivator binding.
University of California
HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.
University of California
N(G)-aminoguanidines from primary amines and the preparation of nitric oxide synthase inhibitors.
University of California
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.
University of California
Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hydrolase (FAAH).
University of California
Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries.
University of California
L-arginine analogs as alternate substrates for nitric oxide synthase.
University of California
Structure-activity relationships of dynorphin a analogues modified in the address sequence.
University of California
Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase.
University of California
[Pro(3)]Dyn A(1-11)-NH(2): a dynorphin analogue with high selectivity for the kappa opioid receptor.
University of California
Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
University of California
Substituted isoquinolines and quinazolines as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
University of California
Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation.
University of California
A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
University of California
Ryanodine action at calcium release channels. 2. relation to substituents of the cyclohexane ring.
University of California
Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin.
University of California
New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation.
University of California
New thymidine triphosphate analogue inhibitors of human immunodeficiency virus-1 reverse transcriptase.
University of California
Identification of oxidation product of arbutin in mushroom tyrosinase assay system.
University of California
Investigation of the PDZ domain ligand binding site using chemically modified peptides.
University of California
Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.
University of California
Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
University of California
Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.
University of California
Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosis.
University of California
Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase.
University of California
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
University of California
A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection.
University of California
Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.
University of California
Activation of the endocannabinoid system by organophosphorus nerve agents.
University of California
Structure-guided development of affinity probes for tyrosine kinases using chemical genetics.
University of California
A clickable inhibitor reveals context-dependent autoactivation of p90 RSK.
University of California
Targeting multiple chorismate-utilizing enzymes with a single inhibitor: validation of a three-stage design.
University of California
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
University of California
Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.
University of California
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases.
University of California
Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy.
University of California
Substrate specificity effects of lipoxygenase products and inhibitors on soybean lipoxygenase-1.
University of California
Divergent modes of enzyme inhibition in a homologous structure-activity series.
University of California
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
University of California
4-Phenoxybutoxy-substituted heterocycles--a structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1.3.
University of California
Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.
University of California
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice.
University of California
Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method.
University of California
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels.
University of California
Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis.
University of California
Potency and selectivity of trifluoroacetylimino and pyrazinoylimino nicotinic insecticides and their fit at a unique binding site niche.
University of California
Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling.
University of California
NHE1 inhibition by amiloride- and benzoylguanidine-type compounds. Inhibitor binding loci deduced from chimeras of NHE1 homologues with endogenous differences in inhibitor sensitivity.
University of California
Structural bioinformatics-based design of selective, irreversible kinase inhibitors.
University of California
An analysis of phakellin and oroidin structures stimulated by further study of an Agelas sponge.
University of California
Cationic reduction of bastadin-4 to bastadin-5. Preparation of 5-[2h]-bastadin-5 by site-specific isotopic labeling.
University of California
New bioactive flavonoids and stilbenes in cubé resin insecticide.
University of California
Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes.
University of California
Systematic Study of Heteroarene Stacking Using a Congeneric Set of Molecular Glues for Procaspase-6.
University of California
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist.
University of California
Model of P-Glycoprotein Ligand Binding and Validation with Efflux Substrate Matched Pairs.
University of California
Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disorders.
University of California
Development of Human Carbonic Anhydrase II Heterobifunctional Degraders.
University of California
Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1.
University of California
Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
University of California
Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
University of California
Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
University of California
Novel human lipoxygenase inhibitors discovered using virtual screening with homology models.
University of California
Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.
University of California
Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors.
University of California
6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model.
University of California
Probing the activity differences of simple and complex brominated aryl compounds against 15-soybean, 15-human, and 12-human lipoxygenase.
University of California
Computer-assisted design of selective imidazole inhibitors for cytochrome p450 enzymes.
University of California
Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine Phosphatase.
University of California
2-hydroxy-4-isopropylbenzaldehyde, a potent partial tyrosinase inhibitor.
University of California
NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.
University of California
A novel class of selective non-nucleoside inhibitors of human DNA methyltransferase 3A.
University of California
Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors.
University of California
3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators.
University of California
A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors.
University of California
5-Azidoepibatidine: an exceptionally potent photoaffinity ligand for neuronal alpha 4 beta 2 and alpha 7 nicotinic acetylcholine receptors.
University of California
General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.
University of California
Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
University of California
Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.
University of California
Structural features of azidopyridinyl neonicotinoid probes conferring high affinity and selectivity for mammalian alpha4beta2 and Drosophila nicotinic receptors.
University of California
Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators.
University of California
Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: insight into structure-based ligand design.
University of California
Tyrosylprotein sulfotransferase inhibitors generated by combinatorial target-guided ligand assembly.
University of California
Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis.
University of California
Fipronil-based photoaffinity probe for Drosophila and human beta 3 GABA receptors.
University of California
Discovery of estrogen sulfotransferase inhibitors from a purine library screen.
University of California
Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein-Protein Interactions Using a Cyclic Peptide.
University of California
An increase in side-group hydrophobicity largely improves the potency of ritonavir-like inhibitors of CYP3A4.
University of California
5-Azidoimidacloprid and an acyclic analogue as candidate photoaffinity probes for mammalian and insect nicotinic acetylcholine receptors.
University of California
-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition.
University of California
Optimization of a somatostatin mimetic via constrained amino acid and backbone incorporation.
University of California
Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme.
University of California
A new class of HIV-1 integrase inhibitors: the 3,3,3', 3'-tetramethyl-1,1'-spirobi(indan)-5,5',6,6'-tetrol family.
University of California
Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistry.
University of California
Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.
University of California
Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.
University of California
Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin).
University of California
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity.
University of California
SAR Exploration of Tight-Binding Inhibitors of Influenza Virus PA Endonuclease.
University of California
Ryanodine action at calcium release channels. 1. importance of hydroxyl substituents.
University of California
Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
University of California
Mechanism-based inhibitors of prostaglandin omega-hydroxylase: (R)- and (S)-12-hydroxy-16-heptadecynoic acid and 2,2-dimethyl-12-hydroxy-16-heptadecynoic acid.
University of California
Constrained bithiazoles: small molecule correctors of defective ΔF508-CFTR protein trafficking.
University of California
X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin.
University of California
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
University of California
Interaction of tetrahydrostilbazoles with monoamine oxidase A and B.
University of California
The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.
University of California
Haloperidol-based irreversible inhibitors of the HIV-1 and HIV-2 proteases.
University of California
Bioactive ryanoids from nucleophilic additions to 4,12-seco-4,12-dioxoryanodine.
University of California
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
University of California
Insect nicotinic acetylcholine receptor: conserved neonicotinoid specificity of [(3)H]imidacloprid binding site.
University of California
Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
University of California
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
University of California
Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
University of California
Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system.
University of California
NMR strategy for unraveling structures of bioactive sponge-derived oxy-polyhalogenated diphenyl ethers.
University of California
Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase.
University of California
4'-Methyl-4,5'-bithiazole-based correctors of defective delta F508-CFTR cellular processing.
University of California
Simplified cyclic analogues of bastadin-5. Structure-activity relationships for modulation of the RyR1/FKBP12 Ca2+ channel complex.
University of California
Novel and potent 6-chloro-3-pyridinyl ligands for the alpha4beta2 neuronal nicotinic acetylcholine receptor.
University of California
Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductase.
University of California
Total synthesis and biological evaluation of structural analogues of compactin and dihydromevinolin.
University of California
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
University of California
Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.
University of California
Synthesis and biological evaluation of a monocyclic, fully functional analogue of compactin.
University of California
(+/-)-4-tert-butyl-3-cyano-1-(4-ethynylphenyl)-2,6,7-trioxabi cyclo[2.2.2]octane: synthesis of a remarkably potent GABAA receptor antagonist.
University of California
Studies on semirigid tricyclic analogues of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
University of California
Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol).
University of California
Synthesis and dopaminergic activity of 2-substituted octahydrobenzo[f]quinolines.
University of California
Synthesis and beta-adrenergic antagonist activity of stereoisomeric practolol and propranolol derivatives.
University of California
Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors.
University of California
Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity.
University of California
Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.
University of California
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
University of California
Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer
Kdac Therapeutics
P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
Beijing Tide Pharmaceutical Co.
USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSION
Prilenia Neurotherapeutics
1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE AS USP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS
Mission Therapeutics
Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor
Chia Tai Tianqing Pharmaceutical Group
Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof
Dynavax Technologies
Benzofuran derivative, preparation method thereof and use thereof in medicine
Jiangsu Hengrui Medicine
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
Merck Sharp & Dohme
Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas
Celgene Quanticel Research
Compounds and compositions useful for treating disorders related to NTRK
Blueprint Medicines
Phthalazinone compounds and methods for the treatment of cystic fibrosis
Flatley Discovery Lab
a-Carbonic anhydrases are sulfatases with cyclic diol monosulfate esters.
Dumlupinar University
Semisynthesis of alpha-methyl-gamma-lactones and in vitro evaluation of their activity on protein farnesyltransferase.
Ufr Des Sciences Pharmaceutiques Et Ingenierie De La Sante
Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor ß/d (FABP5-PPARß/d) signaling pathway.
Emory University
1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors
Rottapharm Biotech
The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif.
University of British Columbia
N-formylpyrazolines and N-benzoylpyrazolines as novel inhibitors of mammalian cathepsin B and cathepsin H.
Kurukshetra University
In vitro evaluation of selected benzimidazole derivatives as an antioxidant and xanthine oxidase inhibitors.
Konkuk University
Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta.
Medical College of Georgia
A robust GTP-induced shift in alpha(2)-adrenoceptor agonist affinity in tissue sections from rat brain.
University of Nebraska
Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior.
Bayer
Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.
Vanderbilt University
First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.
Nerviano Medical Sciences
Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting Bacillus anthracis Dihydrofolate Reductase.
University of Connecticut